MultiPlan (NYSE:MPLN - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($5.14) earnings per share for the quarter, beating analysts' consensus estimates of ($13.50) by $8.36, Zacks reports. The firm had revenue of $232.10 million for the quarter, compared to analysts' expectations of $234.77 million. MultiPlan had a negative net margin of 163.30% and a negative return on equity of 12.14%. MultiPlan updated its FY 2025 guidance to EPS.
MultiPlan Stock Performance
Shares of MPLN stock traded down $1.01 during midday trading on Friday, reaching $22.50. 204,858 shares of the company were exchanged, compared to its average volume of 182,062. The business has a 50 day simple moving average of $18.30. The company has a debt-to-equity ratio of 21.73, a quick ratio of 1.05 and a current ratio of 1.05. The stock has a market capitalization of $363.85 million, a P/E ratio of -0.24 and a beta of 0.13. MultiPlan has a 12 month low of $4.80 and a 12 month high of $47.20.
Analyst Upgrades and Downgrades
Separately, Citigroup boosted their price objective on shares of MultiPlan from $10.00 to $12.50 and gave the stock a "neutral" rating in a report on Friday, January 10th.
View Our Latest Stock Analysis on MPLN
MultiPlan Company Profile
(
Get Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Stories
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
